179 related articles for article (PubMed ID: 35099543)
1. Effect of Open-label Placebo on Children and Adolescents With Functional Abdominal Pain or Irritable Bowel Syndrome: A Randomized Clinical Trial.
Nurko S; Saps M; Kossowsky J; Zion SR; Di Lorenzo C; Vaz K; Hawthorne K; Wu R; Ciciora S; Rosen JM; Kaptchuk TJ; Kelley JM
JAMA Pediatr; 2022 Apr; 176(4):349-356. PubMed ID: 35099543
[TBL] [Abstract][Full Text] [Related]
2. Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial.
Ballou S; Kaptchuk TJ; Hirsch W; Nee J; Iturrino J; Hall KT; Kelley JM; Cheng V; Kirsch I; Jacobson E; Conboy L; Lembo A; Davis RB
Trials; 2017 May; 18(1):234. PubMed ID: 28545508
[TBL] [Abstract][Full Text] [Related]
3. Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial.
Lembo A; Kelley JM; Nee J; Ballou S; Iturrino J; Cheng V; Rangan V; Katon J; Hirsch W; Kirsch I; Hall K; Davis RB; Kaptchuk TJ
Pain; 2021 Sep; 162(9):2428-2435. PubMed ID: 33605656
[TBL] [Abstract][Full Text] [Related]
4. Placebos without deception: a randomized controlled trial in irritable bowel syndrome.
Kaptchuk TJ; Friedlander E; Kelley JM; Sanchez MN; Kokkotou E; Singer JP; Kowalczykowski M; Miller FG; Kirsch I; Lembo AJ
PLoS One; 2010 Dec; 5(12):e15591. PubMed ID: 21203519
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.
Weerts ZZRM; Masclee AAM; Witteman BJM; Clemens CHM; Winkens B; Brouwers JRBJ; Frijlink HW; Muris JWM; De Wit NJ; Essers BAB; Tack J; Snijkers JTW; Bours AMH; de Ruiter-van der Ploeg AS; Jonkers DMAE; Keszthelyi D
Gastroenterology; 2020 Jan; 158(1):123-136. PubMed ID: 31470006
[TBL] [Abstract][Full Text] [Related]
6. Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in children and adolescents.
Kaminski A; Kamper A; Thaler K; Chapman A; Gartlehner G
Cochrane Database Syst Rev; 2011 Jul; 2011(7):CD008013. PubMed ID: 21735420
[TBL] [Abstract][Full Text] [Related]
7. Psychological Predictors of Response to Open-Label Versus Double-Blind Placebo in a Randomized Controlled Trial in Irritable Bowel Syndrome.
Ballou S; Haas JW; Iturrino J; Nee J; Kirsch I; Rangan V; Cheng V; Lembo A; Kaptchuk TJ; Kelley JM
Psychosom Med; 2022 Jul-Aug 01; 84(6):738-746. PubMed ID: 35412513
[TBL] [Abstract][Full Text] [Related]
8. A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation.
Rao S; Lembo AJ; Shiff SJ; Lavins BJ; Currie MG; Jia XD; Shi K; MacDougall JE; Shao JZ; Eng P; Fox SM; Schneier HA; Kurtz CB; Johnston JM
Am J Gastroenterol; 2012 Nov; 107(11):1714-24; quiz p.1725. PubMed ID: 22986440
[TBL] [Abstract][Full Text] [Related]
9. Home-Based Hypnotherapy Self-exercises vs Individual Hypnotherapy With a Therapist for Treatment of Pediatric Irritable Bowel Syndrome, Functional Abdominal Pain, or Functional Abdominal Pain Syndrome: A Randomized Clinical Trial.
Rutten JMTM; Vlieger AM; Frankenhuis C; George EK; Groeneweg M; Norbruis OF; Tjon A Ten W; van Wering HM; Dijkgraaf MGW; Merkus MP; Benninga MA
JAMA Pediatr; 2017 May; 171(5):470-477. PubMed ID: 28346581
[TBL] [Abstract][Full Text] [Related]
10. Acute exacerbation of pain in irritable bowel syndrome: efficacy of phloroglucinol/trimethylphloroglucinol. A randomized, double-blind, placebo-controlled study.
Chassany O; Bonaz B; Bruley DES Varannes S; Bueno L; Cargill G; Coffin B; Ducrotté P; Grangé V
Aliment Pharmacol Ther; 2007 May; 25(9):1115-23. PubMed ID: 17439513
[TBL] [Abstract][Full Text] [Related]
11. Antidepressants for chronic non-cancer pain in children and adolescents.
Cooper TE; Heathcote LC; Clinch J; Gold JI; Howard R; Lord SM; Schechter N; Wood C; Wiffen PJ
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012535. PubMed ID: 28779487
[TBL] [Abstract][Full Text] [Related]
12. Psyllium Fiber Reduces Abdominal Pain in Children With Irritable Bowel Syndrome in a Randomized, Double-Blind Trial.
Shulman RJ; Hollister EB; Cain K; Czyzewski DI; Self MM; Weidler EM; Devaraj S; Luna RA; Versalovic J; Heitkemper M
Clin Gastroenterol Hepatol; 2017 May; 15(5):712-719.e4. PubMed ID: 27080737
[TBL] [Abstract][Full Text] [Related]
13. Octatropine methyl bromide and diazepam combination (Valpinax) in patients with irritable bowel syndrome: a multicentre, randomized, placebo-controlled trial.
Pace F; Maurano A; Ciacci C; Savarino V; Attili A; Iaquinto G; Magni E; Porro GB
Eur Rev Med Pharmacol Sci; 2010 Mar; 14(3):155-62. PubMed ID: 20391952
[TBL] [Abstract][Full Text] [Related]
14. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM
Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study.
Wittmann T; Paradowski L; Ducrotté P; Bueno L; Andro Delestrain MC
Aliment Pharmacol Ther; 2010 Mar; 31(6):615-24. PubMed ID: 20003095
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
[TBL] [Abstract][Full Text] [Related]
17. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
[TBL] [Abstract][Full Text] [Related]
18. Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome.
Saito YA; Almazar AE; Tilkes KE; Choung RS; Van Norstrand MD; Schleck CD; Zinsmeister AR; Talley NJ
Aliment Pharmacol Ther; 2019 Feb; 49(4):389-397. PubMed ID: 30663077
[TBL] [Abstract][Full Text] [Related]
19. Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
Lembo A; Pimentel M; Rao SS; Schoenfeld P; Cash B; Weinstock LB; Paterson C; Bortey E; Forbes WP
Gastroenterology; 2016 Dec; 151(6):1113-1121. PubMed ID: 27528177
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
Bensoussan A; Kellow JE; Bourchier SJ; Fahey P; Shim L; Malcolm A; Boyce P
Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1946-54.e1. PubMed ID: 26133902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
